CD274 and head and neck squamous cell carcinoma: Interestingly, an ongoing phase II trial (NCT04847466) is evaluating the effectiveness of irradiated PD-L1 CAR-NK cells in subjects with R/M gastric cancer or HNSCC in combination with pembrolizumab and N-803.